Predictive, preventive, and personalized medicine in statin-treated patients with NSTE-ACS, HFpEF, and type 2 diabetes: a data-driven model for long-term residual risk assessment.

Li Z, Liu H, Xu L, Yin W, Zhu J, Zhou B, Wu B, Zhu T, Li H, Liu J, Wang Y, Wang J

Open source

DOI
10.1007/s13167-026-00467-2
Published
2026 Sep
Container
The EPMA journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13167-026-00467-2,
  title = {Predictive, preventive, and personalized medicine in statin-treated patients with NSTE-ACS, HFpEF, and type 2 diabetes: a data-driven model for long-term residual risk assessment.},
  author = {Li Z and Liu H and Xu L and Yin W and Zhu J and Zhou B and Wu B and Zhu T and Li H and Liu J and Wang Y and Wang J},
  year = {2026},
  journal = {The EPMA journal},
  doi = {10.1007/s13167-026-00467-2},
  url = {https://doi.org/10.1007/s13167-026-00467-2}
}

RIS

TY  - JOUR
TI  - Predictive, preventive, and personalized medicine in statin-treated patients with NSTE-ACS, HFpEF, and type 2 diabetes: a data-driven model for long-term residual risk assessment.
AU  - Li Z
AU  - Liu H
AU  - Xu L
AU  - Yin W
AU  - Zhu J
AU  - Zhou B
AU  - Wu B
AU  - Zhu T
AU  - Li H
AU  - Liu J
AU  - Wang Y
AU  - Wang J
PY  - 2026
JO  - The EPMA journal
DO  - 10.1007/s13167-026-00467-2
UR  - https://doi.org/10.1007/s13167-026-00467-2
ER  - 

APA

Z, L., H, L., L, X., W, Y., J, Z., B, Z., B, W., T, Z., H, L., J, L., Y, W., & J, W. (2026). Predictive, preventive, and personalized medicine in statin-treated patients with NSTE-ACS, HFpEF, and type 2 diabetes: a data-driven model for long-term residual risk assessment.. The EPMA journal. https://doi.org/10.1007/s13167-026-00467-2

Source records